Literature DB >> 1978043

Oral treatment of late borreliosis with roxithromycin plus co-trimoxazole.

R Gasser, J Dusleag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1978043     DOI： 10.1016/0140-6736(90)92801-n

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  In vitro activity of trimethoprim against Borrelia burgdorferi.

Authors:  E C Reisinger; I Wendelin; R Gasser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

2.  Reversal of Borrelia burgdorferi associated dilated cardiomyopathy by antibiotic treatment?

Authors:  R Gasser; F Fruhwald; M Schumacher; G Seinost; E Reisinger; B Eber; A Keplinger; R Horvath; B Sedaj; W Klein; K Pierer
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

3.  Inactivation of diaminopyrimidines and sulfonamides in Barbour-Stoenner-Kelly medium for isolation of Borrelia burgdorferi.

Authors:  E C Reisinger; I Wendelin; R Gasser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

4.  Roxithromycin in the treatment of Lyme disease--update and perspectives.

Authors:  R Gasser; I Wendelin; E Reisinger; J Bergloff; B Feigl; I Schafhalter; B Eber; M Grisold; W Klein
Journal:  Infection       Date:  1995       Impact factor: 3.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.